Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Here you'll find all the latest news from DPUK.

Cumulative life adversity impacts cognition in later adulthood

New research reveals the association between cumulative life course adversity, depression, and cognitive performance. The findings are published in the scientific journal Nature Scientific Reports.

Digital healthcare company Five Lives joins DPUK consortium as industry partner

DPUK is delighted to welcome the health technology company Five Lives as its newest industry partner.

Reaction: UK government confirms major new funding for dementia research

The UK government has announced the launch of a ‘national mission’ to tackle dementia, pledging again to double research funding to £160m per year by 2024.

Diadem partners with DPUK to advance diagnosis and treatment of Alzheimer’s disease

Diadem SpA, a company developing AlzoSure Predict, the first blood-based test for the early prediction of progression to Alzheimer’s disease, has joined DPUK as an industry partner.

Researchers use DPUK Data Portal to explore pathways linking social and lifestyle factors with cognitive function

A new study in the DPUK Data Portal has found that social and lifestyle factors – such as education, income and physical activity – have a direct effect on cognitive performance. The researchers also showed that late-life lifestyle factors may help preserve cognitive function indirectly by reducing the degeneration of brain cells.

Study finds childhood deprivation is linked to faster cognitive decline

Our circumstances and experiences in childhood can have lasting consequences for our thinking skills, according to a new study funded by Dementias Platform UK.

DPUK Data Portal passes 1,000 cohort access requests

Researchers have made more than 1,000 applications to access cohorts within the DPUK Data Portal.

Genetic and activity information will enhance detail within Great Minds volunteer registry

DPUK’s Great Minds register gives researchers access to more than 6,800 well-characterised volunteers who are ready and willing to take part in dementia studies.

Study in DPUK Data Portal finds recurrent depression affects cognition in over-50s

A large-scale analysis of two UK datasets has shown that recurrent depression affects performance in several tests of thinking skills. However, this difference was not altered by taking anti-inflammatory medications such as Ibuprofen, suggesting that neuroinflammation may not be the underlying process driving depression’s effect on cognition.

New study begins measuring brain scans to score brain health

Researcher Dr Jodi Watt is to examine thousands of magnetic resonance imaging (MRI) brain scans to identify patterns of brain health. Based at the Glasgow Royal Infirmary, Dr Watt will be using the UK Biobank Cohort and the European Prevention of Alzheimer’s Dementia (EPAD) cohort for her exciting postdoctoral project.

DPUK Director signs open letter calling for dementia 'medicines taskforce'

DPUK Director Professor John Gallacher has co-signed an open letter to the UK prime minister, published by the Sunday Times, calling for greater investment in dementia research, taking inspiration from the COVID-19 vaccines effort.

Cognitive frailty confirmed as a feature of normal ageing rather than underlying dementia

A new study by a DPUK-funded researcher has provided evidence that cognitive frailty is a feature of unhealthy yet normal ageing, rather than a sign of impending dementia.

New AI model accurately predicts the best dementia medication for each patient

A team of researchers has developed the first model for prescribing personalised medication to treat dementia. The model uses artificial intelligence (AI) to determine the most effective dementia medication for an individual based on factors such as their age, sex, and memory assessment scores.

People with both type-2 diabetes and high blood pressure have worse brain health than those with just one of these conditions

A new study co-authored by a DPUK-funded researcher has found that people with type-2 diabetes have worse overall brain health than people with high blood pressure, and that those with both conditions have even poorer brain health.

Study finds hearing aid use is linked to slower decline in thinking skills

A new study has found that hearing loss increases the risk of a precursor to dementia called mild cognitive impairment – but this increased risk is not present in people who wear hearing aids.

New research suggests lowering brain cell excitability could help prevent Alzheimer’s disease

Previous research has found an inconsistent relationship with dementia and benzodiazepines – a group of sedative drugs used to treat conditions such as anxiety and insomnia. Now, using the DPUK Data Portal, a team of researchers in France has investigated the association further and found compelling evidence that benzodiazepines reduce some of the hallmarks of Alzheimer’s disease.

DPUK receives funding to run four art workshops to improve diversity in dementia research

Dementias Platform UK has been awarded a £23,000 grant from Alzheimer’s Research UK’s Inspire Fund, which supports public engagement initiatives to improve understanding of dementia and dementia research.

Study finds over 200 common medications are associated with dementia

A team of UK researchers has been investigating the association between prescription medications and dementia using a dataset funded by Dementias Platform UK (DPUK).

PhD student develops new tool to make studying brain waves easier and more accurate

Brain waves provide an insight into brain cell activity, but they are notoriously difficult to isolate and analyse. Now, a PhD candidate at the University of Oxford has developed a new method to help researchers study brain waves that has exciting implications for detecting and treating dementia.

Apply now for the DPUK Spring Academy for beginner cohort analysts

DPUK's all-new Spring Academy is a week-long series of lectures, presentations and guided tutorials giving researchers an introduction to cohort data analysis techniques.

Load More